Annual EBITDA
-$40.58 M
-$27.53 M-211.10%
December 31, 2021
Summary
- As of February 10, 2025, PLXP annual EBITDA is -$40.58 million, with the most recent change of -$27.53 million (-211.10%) on December 31, 2021.
- During the last 3 years, PLXP annual EBITDA has fallen by -$42.82 million (-1908.89%).
Performance
PLXP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$10.78 M
+$3.71 M+25.59%
September 30, 2022
Summary
- As of February 10, 2025, PLXP quarterly EBITDA is -$10.78 million, with the most recent change of +$3.71 million (+25.59%) on September 30, 2022.
- Over the past year, PLXP quarterly EBITDA has dropped by -$992.00 thousand (-10.13%).
Performance
PLXP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$64.21 M
-$992.00 K-1.57%
September 30, 2022
Summary
- As of February 10, 2025, PLXP TTM EBITDA is -$64.21 million, with the most recent change of -$992.00 thousand (-1.57%) on September 30, 2022.
- Over the past year, PLXP TTM EBITDA has dropped by -$40.86 million (-174.97%).
Performance
PLXP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PLXP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -211.1% | -10.1% | -175.0% |
| 3 y3 years | -1908.9% | -677.7% | -230.2% |
| 5 y5 years | -169.2% | -197.6% | -230.2% |
PLXP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +92.9% | +58.3% | at low |
| 5 y | 5-year | +211.1% | at low | -735.5% | +92.9% | +3722.5% | at low |
| alltime | all time | -1908.9% | at low | -303.9% | +92.9% | -2962.2% | at low |
PLx Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$10.78 M(-25.6%) | -$64.21 M(+1.6%) |
| Jun 2022 | - | -$14.49 M(-20.1%) | -$63.22 M(+14.5%) |
| Mar 2022 | - | -$18.14 M(-12.8%) | -$55.21 M(+36.1%) |
| Dec 2021 | -$40.58 M(+211.1%) | -$20.80 M(+112.5%) | -$40.56 M(+73.7%) |
| Sep 2021 | - | -$9.79 M(+51.0%) | -$23.35 M(+40.3%) |
| Jun 2021 | - | -$6.48 M(+85.6%) | -$16.64 M(+22.1%) |
| Mar 2021 | - | -$3.49 M(-2.7%) | -$13.63 M(+61.4%) |
| Dec 2020 | -$13.04 M(-33.7%) | -$3.59 M(+16.5%) | -$8.44 M(+27.4%) |
| Sep 2020 | - | -$3.08 M(-11.2%) | -$6.63 M(+294.6%) |
| Jun 2020 | - | -$3.47 M(-304.5%) | -$1.68 M(-76.8%) |
| Mar 2020 | - | $1.70 M(-195.7%) | -$7.24 M(-62.8%) |
| Dec 2019 | -$19.66 M(-976.4%) | -$1.77 M(-195.0%) | -$19.44 M(+35.3%) |
| Sep 2019 | - | $1.87 M(-120.7%) | -$14.37 M(-25.6%) |
| Jun 2019 | - | -$9.03 M(-14.1%) | -$19.32 M(+42.5%) |
| Mar 2019 | - | -$10.51 M(-418.6%) | -$13.55 M(-704.2%) |
| Dec 2018 | $2.24 M(-114.9%) | $3.30 M(-207.1%) | $2.24 M(-125.9%) |
| Sep 2018 | - | -$3.08 M(-5.7%) | -$8.65 M(-5.9%) |
| Jun 2018 | - | -$3.26 M(-161.7%) | -$9.19 M(+8.9%) |
| Mar 2018 | - | $5.29 M(-169.6%) | -$8.44 M(-44.0%) |
| Dec 2017 | -$15.07 M | -$7.59 M(+109.6%) | -$15.07 M(+69.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$3.62 M(+44.2%) | -$8.90 M(+40.6%) |
| Jun 2017 | - | -$2.51 M(+86.7%) | -$6.33 M(+20.3%) |
| Mar 2017 | - | -$1.35 M(-5.4%) | -$5.26 M(-46.0%) |
| Dec 2016 | -$4.81 M(-74.4%) | -$1.42 M(+35.1%) | -$9.75 M(-29.6%) |
| Sep 2016 | - | -$1.05 M(-27.1%) | -$13.84 M(-22.3%) |
| Jun 2016 | - | -$1.44 M(-75.2%) | -$17.82 M(-12.7%) |
| Mar 2016 | - | -$5.83 M(+5.8%) | -$20.41 M(+8.8%) |
| Dec 2015 | -$18.76 M(+38.2%) | -$5.51 M(+9.6%) | -$18.76 M(+13.5%) |
| Sep 2015 | - | -$5.03 M(+24.6%) | -$16.53 M(+7.7%) |
| Jun 2015 | - | -$4.03 M(-3.7%) | -$15.34 M(+0.7%) |
| Mar 2015 | - | -$4.19 M(+27.9%) | -$15.23 M(+12.1%) |
| Dec 2014 | -$13.58 M(+238.4%) | -$3.27 M(-14.8%) | -$13.58 M(+8.1%) |
| Sep 2014 | - | -$3.84 M(-2.0%) | -$12.56 M(+29.4%) |
| Jun 2014 | - | -$3.92 M(+54.1%) | -$9.71 M(+57.8%) |
| Mar 2014 | - | -$2.54 M(+12.9%) | -$6.15 M(+53.2%) |
| Dec 2013 | -$4.01 M(+117.7%) | -$2.25 M(+127.3%) | -$4.01 M(+127.9%) |
| Sep 2013 | - | -$991.00 K(+172.9%) | -$1.76 M(+128.7%) |
| Jun 2013 | - | -$363.20 K(-10.7%) | -$769.80 K(+89.3%) |
| Mar 2013 | - | -$406.60 K | -$406.60 K |
| Dec 2012 | -$1.84 M | - | - |
FAQ
- What is PLx Pharma annual EBITDA?
- What is the all time high annual EBITDA for PLx Pharma?
- What is PLx Pharma annual EBITDA year-on-year change?
- What is PLx Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for PLx Pharma?
- What is PLx Pharma quarterly EBITDA year-on-year change?
- What is PLx Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for PLx Pharma?
- What is PLx Pharma TTM EBITDA year-on-year change?
What is PLx Pharma annual EBITDA?
The current annual EBITDA of PLXP is -$40.58 M
What is the all time high annual EBITDA for PLx Pharma?
PLx Pharma all-time high annual EBITDA is $2.24 M
What is PLx Pharma annual EBITDA year-on-year change?
Over the past year, PLXP annual EBITDA has changed by -$27.53 M (-211.10%)
What is PLx Pharma quarterly EBITDA?
The current quarterly EBITDA of PLXP is -$10.78 M
What is the all time high quarterly EBITDA for PLx Pharma?
PLx Pharma all-time high quarterly EBITDA is $5.29 M
What is PLx Pharma quarterly EBITDA year-on-year change?
Over the past year, PLXP quarterly EBITDA has changed by -$992.00 K (-10.13%)
What is PLx Pharma TTM EBITDA?
The current TTM EBITDA of PLXP is -$64.21 M
What is the all time high TTM EBITDA for PLx Pharma?
PLx Pharma all-time high TTM EBITDA is $2.24 M
What is PLx Pharma TTM EBITDA year-on-year change?
Over the past year, PLXP TTM EBITDA has changed by -$40.86 M (-174.97%)